Amneal Pharmaceuticals, Inc. Class A Common Stock

AMRX · Moat type: REGULIERUNG

MoatScore

6/10

Fair Value

15 USD

Margin of Safety

-15.9 %

Rating

BEOBACHTEN

GESCHÄFTSMODELL Amneal Pharmaceuticals develops, manufactures and markets generic drugs and specialty pharmaceuticals in the US and internationally, generating revenue through volume sales of regularly approved generic drugs and through a growing portfolio of specialty medicines (including biosimilars and CNS products).

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.